Skip to main content
OpenTrials
Completed

NCT Number: NCT05384301

Effects of Urban Afforestation Activity on Mood, Stress, and Anxiety

This single-group pretest-posttest clinical trial aims to evaluate the effects of a single-session afforestation activity on mood, stress, and anxiety in a sample of adults.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Granada, Faculty of Health Sciences

Granada, Andalusia, 18071, Spain

About this study

The participants will perform an afforestation activity for a single session of 90 minutes. The therapist will direct the participants' attention to the visual, auditory, olfactory, and tactile features of the surrounding environment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults between 18 and 65 years.
  • Any sex and gender.

Exclusion criteria

  • Intake of any psychotropic medication.
  • Other severe or medically unstable diseases that may interfere with participation.
  • Severe cognitive impairment (Mini-Mental State Examination score < 17 out of 30 points).
  • Severe mental disorders in the acute phase or symptomatic phase.
  • Severe intellectual disability.
  • Behavioural alterations as this may interfere with their participation.

Treatment and study plan

Urban Afforestation Program

Other

An afforestation program based on land cultivation and transplantation of several plants for 90 minutes will be implemented.

Other names: Nature-based activity, Afforestation activity

Primary outcomes

  1. Mood

    Time frame: Change from baseline the total mood disturbance after 90 minutes.

    The Spanish adaptation of the 30-item Short Form of the Profile of Mood States will be utilised. There are five questions situated under each mood factor of Anger, Fatigue, Vigour, Friendliness, Tension, and Depressed Mood, which will be rated on a five-point scale starting from 0 indicating "not at all" up to 4 indicating "a lot" to evaluate the current feelings. Higher scores on the vigour and friendliness subscale indicate more positive mood, and higher scores on the remaining subscales indicate more negative mood.

Secondary outcomes

  1. State stress

    Time frame: Change from baseline state stress after 90 minutes.

    The perceived stress will be assessed by the 100-mm Visual Analogue Scale, where endpoints are labelled as "None" and "As bad as it could be" from left to right. The scale will yield a single quantitative variable regarded as the state stress score, which is measured by the distance between the far-left end and the participant's mark on the line in millimetres. Lower scores indicate less stress at the moment.

  2. State anxiety

    Time frame: Change from baseline state anxiety after 90 minutes.

    The 100-mm Visual Analogue Scale for state anxiety will be employed. The endpoints of the scale are labelled as "None" and "As bad as it could be" from left to right. The distance in millimetres between the far-left end and the participant's mark will be regarded as the state anxiety score. Lower scores indicate less anxiety at the moment.

Sponsors and collaborators

Lead sponsor

Universidad de Granada

Other

Registry information

Official study title

Effects of an Urban Afforestation Activity on Mood, Stress, and Anxiety of Adults

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
May 20, 2022
Registry last updated
Jun 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.